Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$46.37 - $57.58 $357,049 - $443,366
-7,700 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$40.22 - $62.0 $12,066 - $18,600
-300 Reduced 3.75%
7,700 $396,000
Q4 2019

Feb 11, 2020

BUY
$57.95 - $66.61 $463,600 - $532,880
8,000 New
8,000 $494,000
Q1 2019

May 07, 2019

SELL
$69.08 - $105.66 $269,412 - $412,074
-3,900 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$65.41 - $84.65 $614,854 - $795,710
-9,400 Reduced 70.68%
3,900 $276,000
Q3 2018

Nov 13, 2018

BUY
$85.46 - $126.37 $1.14 Million - $1.68 Million
13,300 New
13,300 $1.14 Million
Q2 2018

Aug 08, 2018

SELL
$81.85 - $120.51 $3.57 Million - $5.25 Million
-43,600 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$57.91 - $92.15 $2.52 Million - $4.02 Million
43,600 New
43,600 $3.53 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $193M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.